The effect of Arnebia euchchroma and Phenytoin Cream on pain and episiotomy wound healing

Phase 3

Recruiting

Conditions: Condition 1: Pain severity. Condition 2: Wound healing.
Other chronic postprocedural pain
Disruption of perineal obstetric wound
G89.28
O90.1

Registration Number: IRCT20220816055724N2

Lead Sponsor: Arak University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 120

Inclusion Criteria

Normal pregnancy and delivery
Age between 15-45
Primeparous
Body mass index (after delivery) between 18.5-30 kilograms per square meter
Having at least reading and writing literacy

Exclusion Criteria

Gestational age below 37 weeks or above 42 weeks
Suffering from diseases that interfere with wound healing (such as anemia, infection and wounds in the perineum, diabetes, blood pressure, skin, heart, kidney, lung diseases, coagulation disorder, immunodeficiency, hemophilia, connective tissue disorder, depression, malnutrition, mental illness, cancer)
Taking drugs effective on wound healing by the mother (anticoagulants, antidepressants, antiepileptics), alcohol, smoking, glucocorticoids, immune system suppressors, antibiotics, and narcotics and psychotropic drugs, not doing chemotherapy
The duration of rupture of the water bag more than 18 hours
Instrumental vaginal delivery with medial or lateral episiotomy incision
Non spontaneous removal of the placenta
History of injury or previous surgery and visible lesions in the perineum (genital warts, hemorrhoids) and persistent constipation (according to the patient's statement)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain severity. Timepoint: Days 1, 5 and 15 after delivery. Method of measurement: Using the VAS pain questionnaire and Disposable paper ruler.;Wound healing. Timepoint: Days 1, 5 and 15 after delivery. Method of measurement: Using the Reeda pain questionnaire.

Secondary Outcome Measures